^○Akinao Okamoto¹, Fujigaki Hidetsugu², Iriyama Chisako¹, Goto Naoe¹, Yamamoto Hideyuki¹, Mihara Keichiro³, Inaguma Yoko⁴, Miura Yasuo⁵, Furukawa Katsuya⁶, Yamamoto Yukiya⁷, Akatsuka Yoshiki⁸, Kasahara Senji⁹, Miyao Kotaro¹⁰, Masataka Okamoto¹, Kuniaki Saito², Akihiho Tomita¹ (1.Department of Hematology, Fujita Health University School of Medicine, 2.Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, 3.International Center for Cell and Gene Therapy, Fujita Health University School of Medicine, 4.Department of Clinical General Medicine, Fujita Health University School of Medicine, 5.Department of Transfusion Medicine and Cell Therapy, Fujita Health University School of Medicine, 6.Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 7.Department of Biochemical and Sciences, Chubu University, Kasugai, 8.Department of Immunology, Nagoya University Graduate School of Medicine, 9.Department of Hematology, Gifu Municipal Hospital, 10.Department of Hematology and Oncology, Anjo Kosei Hospital)

^○Yoshiko Hashii^1,7, Keizo Horibe^2,7, Yuka Iijima^2,7, Tatsutoshi Nakahata^3,7, Keiko Yagi^4,7, Hara Jyunichi^5,7, Toshihiko Imamura^6,7 (1.Department of Pediatrics, Osaka International Cancer Institute, 2.Clinical Research Center, National Hospital Organization Nagoya Medical Center, 3.Center for iPS Cell Research and Application, Kyoto University, 4.Yumura Clinic, 5.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 6.Department of Pediatrics, Kyoto Prefectural University of Medicine, 7.Japan Association of Childhood Leukemia Study)

^○Emi Kemmoku¹, Harumi Kato¹, Masamitsu Yanada¹, Hirofumi Taji¹, Toko Saito¹, Seiichi Kato², Kazuhito Yamamoto¹ (1.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, 2.Department of Pathology and Molecular Diagnostic, Aichi Cancer Center Hospital)

^○Makoto Ito, Yasuhiko Harada, Yoshitoyo Kagami, Junji Hiraga (Department of Hematology, Toyota Kosei Hospital)

^○Yao Neng Teo¹, Yao Hao Teo¹, Lay Poh Khoo², Esther Wei Yin Chang^2,3, Ya Hwee Tan^2,3, Jianbang Chiang^2,3, Valerie Shiwen Yang^2,3,4,5, Eileen Poon^2,3, Nagavalli Somasundaram^2,3,5, Mohamad Farid^2,3,5, Miriam Tao^2,3,5, Soon Thye Lim^2,3,5, Jason Yongsheng Chan^2,3,5 (1.Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 2.Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 3.SingHealth Duke-NUS Blood Cancer Centre, Singapore, 4.Institute of Molecular and Cell Biology, Singapore, 5.Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore)